RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM)
CUSIP: 76243J105
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 68,385,438
- Total 13F shares
- 67,700,036
- Share change
- -1,760,123
- Total reported value
- $3,546,202,706
- Put/Call ratio
- 9.7%
- Price per share
- $52.39
- Number of holders
- 175
- Value change
- -$85,917,668
- Number of buys
- 88
- Number of sells
- 73
Quarterly Holders Quick Answers
What is CUSIP 76243J105?
CUSIP 76243J105 identifies RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76243J105:
Top shareholders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
11%
|
7,312,391
|
$300,246,774 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.9%
|
6,741,923
|
$276,823,359 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
9.4%
|
6,398,365
|
$262,716,867 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8.9%
|
6,084,412
|
$249,825,957 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
7.7%
|
5,288,635
|
$217,151,353 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5%
|
3,446,579
|
$141,516,534 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
3,360,695
|
$137,990,136 | — | 30 Jun 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
4.3%
|
2,909,956
|
$119,482,793 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.5%
|
2,371,304
|
$97,365,742 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
2,003,882
|
$82,279,395 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.4%
|
1,660,784
|
$68,191,791 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.2%
|
1,500,000
|
$61,590,000 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.9%
|
1,280,493
|
$52,577,043 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,252,689
|
$51,445,353 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
|
Company |
1.8%
|
1,225,000
|
$50,298,500 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,182,370
|
$48,548,112 | — | 30 Jun 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
1,000,000
|
$41,060,000 | — | 30 Jun 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
1.4%
|
967,243
|
$39,714,998 | — | 30 Jun 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
1.3%
|
922,100
|
$37,861,426 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
801,796
|
$32,921,744 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
704,842
|
$28,940,813 | — | 30 Jun 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.87%
|
593,642
|
$24,373,685 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.77%
|
525,942
|
$21,596,000 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.75%
|
515,000
|
$21,145,900 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
499,448
|
$20,507,336 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.7%
|
475,651
|
$19,530,231 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.69%
|
475,000
|
$19,503,500 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
462,188
|
$18,977,439 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.63%
|
427,958
|
$17,571,955 | — | 30 Jun 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.59%
|
404,242
|
$17,249,006 | — | 30 Jun 2024 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.61%
|
417,000
|
$17,122,020 | — | 30 Jun 2024 | |
| NISA INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.55%
|
374,347
|
$15,370,688 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
276,700
|
$11,361,303 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.4%
|
271,398
|
$11,143,082 | — | 30 Jun 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.4%
|
271,267
|
$11,138,223 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.35%
|
236,431
|
$9,707,858 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.34%
|
232,677
|
$9,553,718 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.34%
|
229,491
|
$9,422,900 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.3%
|
202,326
|
$8,307,505 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
191,871
|
$7,878,223 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
184,662
|
$7,582,222 | — | 30 Jun 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.25%
|
172,647
|
$7,088,886 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
149,119
|
$6,122,826 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.21%
|
146,500
|
$6,015,290 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
140,146
|
$5,754,395 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.17%
|
117,388
|
$4,819,951 | — | 30 Jun 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.16%
|
112,804
|
$4,631,732 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.16%
|
106,809
|
$4,385,578 | — | 30 Jun 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.15%
|
104,132
|
$4,276,000 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.15%
|
103,830
|
$4,263,260 | — | 30 Jun 2024 |
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM) as of Q3 2024
As of 30 Sep 2024,
RHYTHM PHARMACEUTICALS, INC. - Common Stock (RYTM) was held by
175 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,700,036 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock, Inc., BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, NEA Management Company, LLC, Frazier Life Sciences Management, L.P., and STATE STREET CORP.
This page lists
175
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
164
Q3 2024 holders
175
Holder diff
11
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.